Jacek Otlewski Selected Research

Starvation

1/2022	Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells.
10/2018	Translocation of Exogenous FGF1 and FGF2 Protects the Cell against Apoptosis Independently of Receptor Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacek Otlewski Research Topics

Disease

39	Neoplasms (Cancer) 01/2022 - 01/2012
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2016
2	Starvation 01/2022 - 10/2018
2	Breast Neoplasms (Breast Cancer) 10/2021 - 08/2018
2	Hyperthermia 01/2017 - 01/2014
2	Prostatic Neoplasms (Prostate Cancer) 07/2014 - 01/2012
1	Inflammation (Inflammations) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 04/2019
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Carcinogenesis 03/2012
1	Leukemia 03/2007
1	Periodontal Diseases (Periodontal Disease) 03/2006
1	Blindness (Hysterical Blindness) 05/2003
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 04/2003

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
10	Pharmaceutical PreparationsIBA 12/2021 - 11/2015
9	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021 - 01/2012
8	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2022 - 01/2012
8	LigandsIBA 01/2020 - 01/2012
7	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2022 - 01/2017
6	monomethyl auristatin EIBA 12/2021 - 01/2016
6	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2021 - 07/2017
6	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 11/2015
6	Immunoglobulin FragmentsIBA 08/2018 - 03/2012
5	auristatinIBA 01/2022 - 02/2017
4	Drug CarriersIBA 01/2022 - 01/2020
4	AntibodiesIBA 05/2018 - 01/2016
3	Monoclonal AntibodiesIBA 08/2021 - 11/2015
2	StaurosporineIBA 01/2022 - 10/2018
2	LectinsIBA 01/2021 - 01/2019
2	AntigensIBA 01/2021 - 01/2017
2	Peptides (Polypeptides)IBA 01/2021 - 03/2007
2	Galectins (Galectin)IBA 01/2021 - 01/2019
2	Phosphotransferases (Kinase)IBA 04/2019 - 05/2003
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	AnisomycinIBA 01/2022
1	Biological ProductsIBA 10/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	Growth Factor ReceptorsIBA 01/2021
1	Cyclic PeptidesIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	AmanitinsIBA 07/2018
1	Cell Surface ReceptorsIBA 07/2017
1	Surface Antigens (Surface Antigen)IBA 11/2015
1	Brentuximab VedotinIBA 11/2015
1	Ado-Trastuzumab EmtansineIBA 11/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2015
1	ErbB Receptors (EGF Receptor)IBA 01/2014
1	Dextrans (Dextran)FDA Link 01/2014
1	ferric oxide (iron oxide)IBA 01/2014
1	Epidermal Growth Factor (EGF)IBA 03/2012
1	Calcium-Binding ProteinsIBA 03/2012
1	IntegrinsIBA 03/2012
1	S100 Calcium Binding Protein A7IBA 03/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2012
1	GoldIBA 01/2012
1	NanoconjugatesIBA 01/2012
1	Rho Guanine Nucleotide Exchange FactorsIBA 03/2007
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 03/2007
1	plexinIBA 03/2007
1	Cysteine Proteases (Cysteine Protease)IBA 03/2006
1	Gingipain Cysteine EndopeptidasesIBA 03/2006
1	Neurofibromin 2 (Merlin)IBA 04/2003
1	SynteninsIBA 04/2003

Therapy/Procedure

26	Therapeutics 01/2022 - 01/2012
1	Drug Therapy (Chemotherapy) 01/2021
1	Radiotherapy 01/2014